首页>
外国专利>
NANO-TARGETED DELIVERY OF PROTEASE, POLYMERASE INHIBITORS WITH OR WITHOUT IMMUNE MODULATORS IN THE TREATMENT OF HEPATITIS C
NANO-TARGETED DELIVERY OF PROTEASE, POLYMERASE INHIBITORS WITH OR WITHOUT IMMUNE MODULATORS IN THE TREATMENT OF HEPATITIS C
展开▼
机译:肝癌治疗中有或无免疫调节剂的纳米靶向蛋白酶,聚合酶抑制剂的递送
展开▼
页面导航
摘要
著录项
相似文献
摘要
This disclosure concerns novel formulation and Nanoformulations as defined in the specification and compositions comprising combination of HCV protease and polymerase inhibitors, with or without interferon, along with anti-fibrotic/anti-hemolytic agents' combination of naturally driven Polyphenol/Thiols, and Non-anticoagulant GAGs.. These compounds are effective antiviral agents, especially in inhibiting the function of the various genotypes of Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising nano-targeted delivery of novel nanoformulation containing combined composition for HCV and/or hepatic targeted delivery for improved efficacy and safety.
展开▼